Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Aydogan, A. Gundogan, E. Ucar, C. Tasci, S. Gumus, Z. Polat, O. Deniz, E. Tozkoparan, M. Ozkan, H. Bilgic (Ankara, Turkey). Coexistance of idiopathic pulmonary hemosiderosis and celiac disease: Complete remission with gluten free diet. Eur Respir J 2012; 40: Suppl. 56, 3684

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary haemosiderosis in children –cases with long survival Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003 Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Eur Respir J 2015; 45: 1613-1623 Year: 2015 High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 27: 136-142 Year: 2006 Idiopathic pulmonary haemosiderosis revisited Source: Eur Respir J 2004; 24: 162-169 Year: 2004 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Incidence of coeliac disease in patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001 Pulmonary manifestation of chronic granulomatous disease (CGD) Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010 Evaluating disease severity in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017 Year: 2017 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014 Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapy Source: Eur Respir J 2014; 43: 1513-1515 Year: 2014 Exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Reversible pulmonary hypertension associated with multivisceral Whipple's disease Source: Eur Respir J, 57 (2) 2003132; 10.1183/13993003.03132-2020 Year: 2021 Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Familial cases of idiopathic pulmonary fibrosis: Clinical observation Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Familial idiopathic pulmonary fibrosis and "genetic anticipation" Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Peripheral muscle atrophy in patients with cronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 497s Year: 2002